GRP-60367 hydrochloride（Cat No.:I045307）is a synthetic small-molecule inhibitor designed to modulate specific signaling pathways implicated in cancer progression and immune regulation. Supplied as its hydrochloride salt for improved solubility and stability, it selectively targets key kinases or protein–protein interactions that drive tumor cell proliferation, survival, and resistance mechanisms. Preclinical studies suggest potential applications in oncology, particularly in combination therapy to enhance antitumor efficacy. Its favorable pharmacological profile and specificity make GRP-60367 hydrochloride a valuable tool for mechanistic studies and a promising lead compound in the development of targeted cancer therapeutics.